ASH 2020: Dr. Furman Discusses Minimal Residual Disease-Driven Captivate and Murano Studies in Chronic Lymphocytic Leukemia (CLL)
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Usefulness of MRD testing explained!
ASH 2019 MRD Testing: Dr. Chaitra Ujjani’s short video explains the concept of MRD testing and its value in predicting progression free survival.
Related posts
